Hugo Ten Cate

Active 1989–2025

Also published as
Hugo ten Cate
214
Papers
25,834
Citations
92
h-index
198
i10-index

Citations

Citations per year for Hugo Ten Cate1979: 4 citations1980: 2 citations1982: 7 citations1983: 2 citations1984: 1 citations1986: 2 citations1989: 5 citations1990: 6 citations1991: 24 citations1992: 19 citations1993: 25 citations1994: 26 citations1995: 49 citations1996: 66 citations1997: 74 citations1998: 64 citations1999: 61 citations2000: 99 citations2001: 108 citations2002: 93 citations2003: 122 citations2004: 99 citations2005: 88 citations2006: 106 citations2007: 76 citations2008: 77 citations2009: 99 citations2010: 132 citations2011: 130 citations2012: 155 citations2013: 170 citations2014: 171 citations2015: 160 citations2016: 146 citations2017: 110 citations2018: 132 citations2019: 506 citations2020: 758 citations2021: 755 citations2022: 541 citations2023: 359 citations2024: 661 citations2025: 459 citations2026: 17 citations1981: no citations, so this year is not shown1985: no citations, so this year is not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,870 citing papers, 19.4% of this breakdownNetherlands: 802 citing papers, 8.3% of this breakdownUnited Kingdom: 723 citing papers, 7.5% of this breakdownItaly: 633 citing papers, 6.5% of this breakdownGermany: 627 citing papers, 6.5% of this breakdownChina: 510 citing papers, 5.3% of this breakdownCanada: 395 citing papers, 4.1% of this breakdownFrance: 394 citing papers, 4.1% of this breakdownJapan: 267 citing papers, 2.8% of this breakdownSpain: 240 citing papers, 2.5% of this breakdownSwitzerland: 221 citing papers, 2.3% of this breakdownAustralia: 220 citing papers, 2.3% of this breakdown
0%19.4%Other 28.4%

Fields

  • Medicine76.7%
  • Immunology and Microbiology9%
  • Biochemistry, Genetics and Molecular Biology8.1%
  • Engineering1.5%
  • Nursing0.9%
  • Neuroscience0.8%
  • Other3%

Topics

  • Venous Thromboembolism Diagnosis and Management6.5%
  • Blood Coagulation and Thrombosis Mechanisms6.1%
  • Atrial Fibrillation Management and Outcomes4.7%
  • COVID-19 Clinical Research Studies3%
  • Sepsis Diagnosis and Treatment2.7%
  • Platelet Disorders and Treatments2.4%
  • Other74.6%

Coauthors

All papers

Open in search
  1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pietro Ameri, Elena Arbelo, Axel Bauer, Michael A. Borger, Sergio Buccheri, Barbara Casadei, Ovidiu Chioncel, Dobromir Dobrev, Laurent Fauchier, Bruna Gigante, Michael Glikson, Ziad Hijazi, Gerhard Hindricks, Daniela Husser, Borja Ibáñez, Stefan James, Stefan Kääb, Paulus Kirchhof, Lars Køber, Konstantinos C. Koskinas, Thomas Kümler, Gregory Y H Lip, John Mandrola, Nikolaus Marx, John William Mcevoy, Borislava Mihaylova, Richard Mindham, Denisa Muraru, Lis Neubeck, Jens Cosedis Nielsen, Jonas Oldgren, Maurizio Paciaroni, Agnès Pasquet, Eva Prescott, Filip Rega, Francisco Javier Rossello, Marcin Ruciński, Sacha P. Salzberg, Sam Schulman, Philipp Sommer, Jesper Hastrup Svendsen, Jurriën M. ten Berg, Hugo Ten Cate, Ilonca Vaartjes, Christiaan Vrints, Adam Witkowski, Katja Zeppenfeld, Leonard Simoni, B. Kichou, Hamayak Sisakian, Daniel Scherr, Frank Cools, Elnur Smajić, Tchavdar Shalganov, Šime Manola, Panayiotis Avraamides, Miloš Táborský, Axel Brandes, Ahmed M El-Damaty, Priit Kampus, Pekka Raatikainen, Rodrigue Garcia, Kakhaber Etsadashvili, Lars Eckardt, Eleftherios M. Kallergis, László Gellér, Kristján Guðmundsson, Jonathan Lyne, Ibrahim Marai, Furio Colivicchi and 30 more - European Heart Journal 2024 cited by 2,409

  2. Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State

    Authors: , , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2013 cited by 440

  3. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

    Authors: , , , , , , , , , , , , , , , , - Nature Reviews Cardiology 2022 cited by 295

  4. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

    Authors: , , , , , , , - Journal of Thrombosis and Haemostasis 2017 cited by 364

  5. Disseminated Intravascular Coagulation

    Authors: , - New England Journal of Medicine 1999 cited by 1,993

  6. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet Haematology 2019 cited by 219

  7. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications

    Authors: , , , , , , - Critical Reviews in Clinical Laboratory Sciences 2018 cited by 213

  8. EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer

    Authors: , , , , , , , , , , , , - HemaSphere 2022 cited by 98

  9. Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Heart 2022 cited by 48

  10. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

    Authors: , , , , , , , , , , , , , , , , - European Heart Journal 2016 cited by 285

  11. Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa

    Authors: , , , , , - Journal of Thrombosis and Haemostasis 2012 cited by 280

  12. Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease

    Authors: , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2020 cited by 93

  13. Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis

    Authors: , , , - Thrombosis and Haemostasis 2020 cited by 73

  14. Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis

    Authors: , , , , , , , , , , , , , , , , , , , , - Thrombosis Research 2023 cited by 28

  15. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation

    Authors: , , , , , , , , , , , , , , , , , - European Heart Journal 2016 cited by 170

  16. Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease

    Authors: , , , , , - Frontiers in Cardiovascular Medicine 2021 cited by 72

  17. Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation

    Authors: , , , , , , , , , - Respiratory Medicine 2020 cited by 33

  18. The Hemostatic System as a Modulator of Atherosclerosis

    Authors: , , - New England Journal of Medicine 2011 cited by 561

  19. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis

    Authors: , , , , , , - Intensive Care Medicine 2020 cited by 154

  20. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 122

  21. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia

    Authors: , , , , , , - Cells 2021 cited by 88

  22. CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis on Preventing Post‐Thrombotic Syndrome) Trial: Long‐Term Follow‐Up Results

    Authors: , , , , , , , , , , , , , - Journal of the American Heart Association 2021 cited by 74

  23. D-dimer testing: A narrative review

    Authors: , , , , , , , , , , , - Advances in clinical chemistry 2023 cited by 44

  24. The coagulation system in atherothrombosis: Implications for new therapeutic strategies

    Authors: , , - Research and Practice in Thrombosis and Haemostasis 2018 cited by 80